Table 4. Comparative mean [one-way ANOVA (post-hoc)] analysis of different serum parameters across different grades identified in brain tumour patients who participated, Addis Ababa, Ethiopia, 2020.
| Serum parameter | Tumour grade | |||
|---|---|---|---|---|
| Grade I (N = 21) Mean ± SD |
Grade II (N = 14) Mean ± SD |
Grade III (N = 9) Mean ± SD |
Grade IV (N = 6) Mean ± SD |
|
| GSH | 11.96 ± 1.13a | 11.10 ± 0.97a | 10.14 ± 0.22 | 9.46 ± 0.46 |
| GSSG | 0.69 ± 0.02b | 0.71 ± 0.015b | 0.75 ± 0.029 | 0.74 ± 0.035 |
| TOS | 8.43 ± 1.56c | 9.46 ± 0.77c | 11.31 ± 0.79 | 11.96 ± 0.72 |
| TAC | 93.80 ± 4.49d | 84.89 ± 8.39d | 57.89 ± 7.25d | 50.55 ± 3.14d |
| OSI | 9.11 ± 1.79e | 11.26 ± 1.54e | 19.87 ± 3.25e | 23.78 ± 2.65e |
Significant mean difference in GSH
Significant mean difference in GSSG
Significant mean difference in TOS
Significant mean difference in TAC
Significant mean difference in OSI